Course: Support N113
Term: Fall 2023
Correlate the pathophysiology, etiology, and clinical manifestations of patients with alterations in the immune system:
Hypersensitivity reactions (Types I-V)
HIV/AIDS and opportunistic diseases
Cancer and oncologic emergencies
Interpret and analyze procedures and diagnostic tests for alterations in the immune system:
Common tests include CBC with WBC differential, rapid HIV testing, RAST, and biopsy
Understand the importance of tests like CD4 T-cell count and viral load.
Understand pharmacological and non-pharmacological therapies for patients with immune alterations:
Pharmacological: Antihistamines, corticosteroids, antiretroviral therapy (ART)
Non-pharmacological: Lifestyle modifications and self-care strategies
Promote self-care in patients with altered immune systems:
Recognizing allergens, managing medications (e.g., EpiPen), and understanding HIV screening
Infection and cancer prevention and management of side effects from treatments (chemotherapy, radiation)
Identify resources for patients:
Agencies like the National Institute for Allergy and Infectious Diseases and the American Cancer Society
Transmission: Viral RNA becomes viral DNA, altering cellular structure for replication.
Infection Stages:
Asymptomatic chronic infection
Symptomatic chronic infection
AIDS defined by CD4+ count < 200 cells/μL or an AIDS-defining illness.
Common symptoms:
Fever, cough, weakness, nausea/vomiting, diarrhea, etc.
Lymphadenopathy and flu-like symptoms are also prevalent.
Diagnostic Testing:
Tests involving HIV virus antibodies, CD4+ count, and viral load are crucial for monitoring health.
Regular monitoring of vital signs, weight, and lab results (CD4+, viral load).
Promote adherence to ART, provide nutrition and emotional support.
Teaching points include avoiding high-risk behaviors and understanding treatment regimens.
Types of Reactions:
Type I: Immediate (IgE) - Anaphylaxis; requires fast intervention (Epinephrine).
Type II: Cytotoxic (IgM) - Hemolytic reactions; stop transfusion protocols.
Type III: Immune Complex (IgG) - SLE and rheumatoid arthritis.
Type IV: Delayed (cell-mediated) - Poison Ivy or TB tests; 24-48 hours response.
Most common cancers: Lung, breast, colorectal, prostate, skin, stomach.
Key factors in carcinogenesis include environmental and genetic influences.
TNM Staging System:
Stage 0: Cancer in situ
Stage I: Localized tumor
Stage II: Limited local spread
Stage III: Extensive spread
Stage IV: Metastasis
Surgical Options: Tumor resection, debulking, reconstruction.
Radiation Therapy: External and internal forms (Brachytherapy).
Chemotherapy: Important for systemic treatment of cancer, including immunotherapy and targeted agents.
Interventions for Superior Vena Cava Syndrome: Elevate the head of the bed to facilitate blood flow and alleviate symptoms.
Dietary Considerations: High protein diets support healing for patients undergoing treatments.
Managing Chemotherapy Effects: Utilize scheduled antiemetics to combat nausea.
Understanding HIV Patterns: Untreated infection follows a predictable progression; late chronic HIV equals AIDS.
Antiretroviral Drug Purpose: Primarily to decrease viral load, not to cure the infection but to manage it.
Education for Expectant Mothers: Most infants born to HIV-positive mothers are not infected if ART is used during pregnancy.
Rapid HIV Testing Protocol: Positive results necessitate a follow-up blood test for confirmation.
When a patient is stung and has a concern about severe reactions, assess their history of past reactions before providing advice.
Tuberculosis Testing Reaction Type: Positive reactions are characterized by Type IV hypersensitivity.
Change in bowel or bladder habits
Non-healing sore, unusual bleeding, thickening/lump
Indigestion or swallowing issues, changes in warts/moles, nagging cough